Cell signaling by receptor tyrosine kinases
- PMID: 20602996
- PMCID: PMC2914105
- DOI: 10.1016/j.cell.2010.06.011
Cell signaling by receptor tyrosine kinases
Abstract
Recent structural studies of receptor tyrosine kinases (RTKs) have revealed unexpected diversity in the mechanisms of their activation by growth factor ligands. Strategies for inducing dimerization by ligand binding are surprisingly diverse, as are mechanisms that couple this event to activation of the intracellular tyrosine kinase domains. As our understanding of these details becomes increasingly sophisticated, it provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases. Much remains to be learned, however, about the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses.
Figures
Similar articles
-
Tyrosine kinase receptors as attractive targets of cancer therapy.Crit Rev Oncol Hematol. 2004 Apr;50(1):23-38. doi: 10.1016/j.critrevonc.2003.08.004. Crit Rev Oncol Hematol. 2004. PMID: 15094157 Review.
-
Receptor tyrosine kinase activation: From the ligand perspective.Curr Opin Cell Biol. 2020 Apr;63:174-185. doi: 10.1016/j.ceb.2020.01.016. Epub 2020 Feb 27. Curr Opin Cell Biol. 2020. PMID: 32114309 Free PMC article. Review.
-
Receptor tyrosine kinases: from biology to pathology.J Recept Signal Transduct Res. 2011 Dec;31(6):387-94. doi: 10.3109/10799893.2011.625425. Epub 2011 Oct 31. J Recept Signal Transduct Res. 2011. PMID: 22040163 Review.
-
Ligand bias in receptor tyrosine kinase signaling.J Biol Chem. 2020 Dec 25;295(52):18494-18507. doi: 10.1074/jbc.REV120.015190. Epub 2020 Oct 29. J Biol Chem. 2020. PMID: 33122191 Free PMC article. Review.
-
Mechanisms of receptor tyrosine kinase activation in cancer.Mol Cancer. 2018 Feb 19;17(1):58. doi: 10.1186/s12943-018-0782-4. Mol Cancer. 2018. PMID: 29455648 Free PMC article. Review.
Cited by
-
HER4 is a high-affinity dimerization partner for all EGFR/HER/ErbB family proteins.Protein Sci. 2024 Oct;33(10):e5171. doi: 10.1002/pro.5171. Protein Sci. 2024. PMID: 39276020
-
In Silico Screening of Therapeutic Targets as a Tool to Optimize the Development of Drugs and Nutraceuticals in the Treatment of Diabetes mellitus: A Systematic Review.Int J Mol Sci. 2024 Aug 25;25(17):9213. doi: 10.3390/ijms25179213. Int J Mol Sci. 2024. PMID: 39273161 Free PMC article. Review.
-
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.Elife. 2024 Sep 13;12:RP91619. doi: 10.7554/eLife.91619. Elife. 2024. PMID: 39268701 Free PMC article.
-
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review.
-
Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes.Front Dement. 2024 Aug 16;3:1458038. doi: 10.3389/frdem.2024.1458038. eCollection 2024. Front Dement. 2024. PMID: 39221072 Free PMC article. Review.
References
-
- Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, et al. A module of negative feedback regulators defines growth factor signaling. Nat Genet. 2007;39:503–512. - PubMed
-
- Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem. 1997;272:217–221. - PubMed
-
- Barton WA, Tzvetkova-Robev D, Miranda EP, Kolev MV, Rajashankar KR, Himanen JP, Nikolov DB. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat Struct Mol Biol. 2006;13:524–532. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR051886-05/AR/NIAMS NIH HHS/United States
- P50-AR054086/AR/NIAMS NIH HHS/United States
- R01-AR051448/AR/NIAMS NIH HHS/United States
- R01 CA079992-13/CA/NCI NIH HHS/United States
- R01 AR051448/AR/NIAMS NIH HHS/United States
- R01-CA125432/CA/NCI NIH HHS/United States
- R01 AR051448-05/AR/NIAMS NIH HHS/United States
- R01 CA096768/CA/NCI NIH HHS/United States
- R01 CA125432/CA/NCI NIH HHS/United States
- R01 CA079992/CA/NCI NIH HHS/United States
- R01 AR051886/AR/NIAMS NIH HHS/United States
- R01-CA096768/CA/NCI NIH HHS/United States
- P50 AR054086/AR/NIAMS NIH HHS/United States
- R01-AR051886/AR/NIAMS NIH HHS/United States
- R01 CA096768-05/CA/NCI NIH HHS/United States
- R01 CA125432-05/CA/NCI NIH HHS/United States
- P50 AR054086-040003/AR/NIAMS NIH HHS/United States
- R01-CA079992/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous